| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
8e-16 |
| mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
1e-11 |
| mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-11 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
4e-11 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-09 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-09 |
| mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
3e-09 |
| mRNA |
QL-XI-92 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
8e-09 |
| mRNA |
BIX-01294 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-08 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-08 |